What question did this study set out to answer?

To describe the components, time, and intensity of pharmacists' work in managing hypertension within a physician-pharmacist collaborative care model to evaluate relative value in team-based care.

February 20, 2016Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyOpen Access

Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension

View Full Paper

Ask AI

Bookmark

Population

390 patients with multiple cardiovascular risk factors and uncontrolled blood pressure across 32…

Comparison

Physician-pharmacist collaborative model… vs Usual care.

Design

Other, cluster randomized (parent trial)

Follow-up

9 months

Authors

BIBrian J. IsettsAmerican Pharmacists Association DBDaniel E. BuffingtonUniversity of South Florida BCBarry L. CarterPreventive Cardiology

Discussion

Member takes

Implication

Pharmacist-physician hypertension collaboration involves substantial workload with high recommendation acceptance; supports workload valuation frameworks but leaves precise CMS reimbursement models open.

Key Points

To describe the components, time, and intensity of pharmacists' work in managing hypertension within a physician-pharmacist collaborative care model to evaluate relative value in team-based care.
Descriptive workload evaluation within the CAPTION study, a prospective cluster-randomized trial across 32 community-based medical offices in 15 U.S. states.
Analyzed 390 patients with uncontrolled blood pressure and multiple cardiovascular risk factors who received pharmacist-led care over a 9-month intervention window.
Pharmacists recorded time dedicated to pre-visit, face-to-face, and post-visit activities, as well as recommendations made to resolve drug therapy problems.
Across 2,811 pharmacist encounters for 390 patients, care required a mean of 3.44 hours/patient for face-to-face visits and 1.55 hours/patient for pre- and post-visit activities.
Pharmacists addressed drug therapy problems in 43% of patient visits and submitted 1,169 recommendations to physicians, who accepted 1,153 (98.6%) of them.
Patients achieving target blood pressure goals under the primary end point improved from 0% at baseline to 43% at 9 months.

Structured PICO

Population

390 patients with multiple cardiovascular risk factors and uncontrolled blood pressure across 32 community-based medical offices in 15 U.S. states.

Intervention

Physician-pharmacist collaborative model including medical record review, structured assessment, collaboration to achieve goals of therapy, and patient follow-up over 9 months.

Comparator

Usual care (though this descriptive analysis focuses on the intervention arms).

Outcome

Time and intensity of pharmacists' work (estimated time spent in pre-visit, face-to-face care, and post-visit activities, and interventions to resolve drug therapy problems).

A physician-pharmacist collaborative model for hypertension management requires significant pharmacist time investment but results in high physician acceptance of recommendations and improved blood pressure control.

Cite This Study

Isetts et al. (2016) studied this question.

synapsesocial.com/papers/6a7416006e5d70aae1603817 https://doi.org/10.1002/phar.1727

Topics

Hypertension management Women and heart disease Cardiovascular prevention

View Full Paper

Ask AI

Bookmark

Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider